Aptevo Therapeutics (NASDAQ:APVO) just reported results for the second quarter of 2024.
- Aptevo Therapeutics reported earnings per share of -$1.67. This was above the analyst estimate for EPS of -$3.92.
- The company did not report any revenue for the quarter.